Effect of high-dose gammaglobulin on a case of Guillain-Barré syndrome
Autor(es): Ishikawa A, Tanaka S, Fukushima N, Takase A, Wagatsuma Y, Kikuta H, Azuma H
Resumo: We reported an infant case of Guillain-Barré syndrome treated with high-dose gammaglobulin. Gammaglobulin was given at a dose of 1 g/kg/day for 2 consecutive days. Dyspnea disappeared six hours after the start of the infusion. The patient was able to sit 3 days and walk alone 25 days after the end of therapy. Circulating immune complexes were 48 micrograms/ml before the therapy, 95 micrograms/ml and 39 micrograms/ml 10 days and 37 days, respectively, after the therapy.
Imprenta: No to Hattatsu. Brain and Development, v. 25, n. 3, p. 263-266, 1993
Identificador do objeto digital: 10.11251/ojjscn1969.25.263
Descritores: Guillain-Barre Syndrome - Biosynthesis ; Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies ; Guillain-Barre Syndrome - Immunology
Data de publicação: 1993
